P-selectin and sST2 as prognostic biomarkers of cardiovascular events in patients with multiple myeloma following anticancer therapy and severe COVID-19
This study investigates the prognostic value of sST2 and P-selectin as biomarkers for cardiovascular risk in patients with multiple myeloma (MM) who are in remission following anticancer therapy and have experienced severe COVID-19. The topic is of increasing clinical relevance due to the growing in...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2025-07-01
|
| Series: | Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki |
| Subjects: | |
| Online Access: | https://pharmed.zsmu.edu.ua/article/view/329039/323378 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!